Search
Arbutus Biopharma Corp
ABUSAdd to Watchlist
4.860USD
+0.010+0.21%
Market hours 09/24, 15:15（ET）
960.04MMarket Cap
5.86P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.21%
5 Days
-3.76%
1 Month
-6.72%
6 Months
+9.95%
Year to Date
+1.04%
1 Year
+8.97%
Key Figures
4.860Open
5.020High
1.30MVolume
5.86P/E TTM
LossP/E Dynamic
--Dividend TTM
0.66%Turnover Ratio
4.850Prev. Close
4.805Low
6.28MTurnover
LossP/E Static
3.71P/B
0.00%Div Yield TTM
81.55%ROA
5.45052wk High
0.21Volume Ratio
-69.92MNet Profit
197.54MShares
0.8295EPS TTM
0.63Beta
94.73%ROE
3.50052wk Low
4.43%Amplitude
100.00%Gross Margin
960.04MMarket Cap
2.12Reward/Risk
2.86%Risk Rate
More news coming soon, stay tuned...
Arbutus Biopharma Corp's Score
0.05vs previous score
Forecast10.00
Financial Health5.79
Technical2.32
Valuation Dimensions9.46
Institutional Confidence5.00
Risk Assessment6.70
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Arbutus Biopharma Corp Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.03/-0.02
Revenue / Forecast
1.01M/700.00K
Arbutus Biopharma Corp Profile
SectorBiotechnology & Medical Research
Ticker SymbolABUS
Number of employees44
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Roivant Sciences Ltd. | 19.73% |
| Morgan Stanley Investment Management Inc. (US) | 13.01% |
| Whitefort Capital Management, LP | 8.02% |
| Two Seas Capital LP | 6.39% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 24.34% |
| Investment Advisor/Hedge Fund | 22.12% |
| Corporation | 19.73% |
| Investment Advisor | 16.48% |
Related Instruments
+3.25%
+0.98%
+0.13%
+0.51%
+0.43%
+1.13%
+0.23%
-0.69%
+0.43%
+0.89%
+1.20%
-0.64%
-1.00%
0.00%
-1.67%
-0.87%
+5.90%
+1.25%
-1.09%
+0.83%Popular Instruments
51334.900
-155.100 (-0.30%)
30451.800
-26.100 (-0.09%)
7704.700
-2.300 (-0.03%)
14264.000
-158.000 (-1.10%)
65768.000
-361.000 (-0.55%)
6303.200
+13.200 (+0.21%)
94.873
+2.383 (+2.58%)
337.720
+0.700 (+0.21%)
223.800
-1.710 (-0.76%)
4269.470
-16.770 (-0.39%)
FAQs
What is the current price of Arbutus Biopharma Corp (ABUS)?
The current price of Arbutus Biopharma Corp (ABUS) is 4.85.
What is the symbol of Arbutus Biopharma Corp?
The ticker symbol of Arbutus Biopharma Corp is ABUS.
What is the 52-week high of Arbutus Biopharma Corp?
The 52-week high of Arbutus Biopharma Corp is 5.45.
What is the 52-week low of Arbutus Biopharma Corp?
The 52-week low of Arbutus Biopharma Corp is 3.50.
What is the market capitalization of Arbutus Biopharma Corp?
The market capitalization of Arbutus Biopharma Corp is 958.07M.
Is Arbutus Biopharma Corp (ABUS) currently rated as Buy, Hold, or Sell?
According to analysts, Arbutus Biopharma Corp (ABUS) has an overall rating of STRONG BUY, with a price target of 5.50.
What is the Earnings Per Share (EPS TTM) of Arbutus Biopharma Corp (ABUS)?
The Earnings Per Share (EPS TTM) of Arbutus Biopharma Corp (ABUS) is 0.83.